Testicular Germ Cell Tumors in Boys < 10 Years: Results of the Protocol MAHO 98 in Respect to Surgery and Watch & Wait Strategy

Abstract Background: In 1982 the GPOH opened the 1st protocol for germ cell tumors (GCTs) of the testis (MAHO 82). Here the results of the 5th version (MAHO 98) will be offered for boys < 10 year of age. Objectives: In MAHO 98 watch and wait (w & w) strategy after inguinal tumororchiectomy was widened from 2 to 10-year-old boys with YST stage IA (group I); other invasive measures were omitted. Thus the prognostic impact of a non-recommended surgery like transscrotal operation +/− conventional biopsy (group II) can be evaluated. Methods: Clinical diagnosis and staging by ultrasound and tumor marker. In blurry cases, a frozen section was recommended to confirm the diagnosis by histology intraoperatively. Indications for adjuvant chemotherapy were: YST stage IA without elevated AFP, YST stage > IA and all mixed malignant GCTs. Results: From 1998 till 2005 128 boys < 10 years with a testicular GCT were registered. Histology: YST n = 76, teratoma n = 46, mixed malignant GCT n = 6. Tumor stage IA: n = 101. All teratoma patients survive event-free. At all, only 19/82 patients with a malignant GCT received chemotherapy including 5 patients with a tumor progress after w&w (2/49 group I and 3/15 group II patients, respectively) and 1 patient (YST IIIA) with relapse after adjuvant chemotherapy. Transscrotal surgery (n = 18) or tumorenucleation (n = 6) remained without event. Indeed all patients survived. Conclusions: Prognosis of boys < 10 year with a testicular GCT is excellent as ~ 80% will be cured by high inguinal tumororchiectomy alone. w&w is feasible and safe even after not recommended surgery if suitable follow-up is assured at least in stage IA cases.

[1]  I. Leuschner,et al.  Molecular Genetic Analysis of Bilateral Ovarian Germ Cell Tumors , 2012, Klinische Pädiatrie.

[2]  D. Orbach,et al.  Rare Cancers in Children – The EXPeRT Initiative: A Report from the European Cooperative Study Group on Pediatric Rare Tumors , 2012, Klinische Pädiatrie.

[3]  A. Horwich,et al.  EAU guidelines on testicular cancer: 2011 update. , 2011, European urology.

[4]  J. M. Garat,et al.  Prepubertal testicular tumours and efficacy of testicular preserving surgery , 2011, BJU international.

[5]  G. Henze,et al.  High Reliability of Scrotal Ultrasonography in the Management of Childhood Primary Testicular Neoplasms , 2011, Klinische Padiatrie.

[6]  I. Brecht,et al.  Care for Rare Cancers: Improved Care Requires Improved Communication , 2010, Klinische Padiatrie.

[7]  S. Alanee,et al.  Paediatric testicular cancer: an updated review of incidence and conditional survival from the Surveillance, Epidemiology and End Results database , 2009, BJU international.

[8]  A. Tannapfel,et al.  Surgery in Infants and Children with Testicular and Paratesticular Tumours: A Single Centre Experience Over a 25-Year-Period* , 2007, Klinische Padiatrie.

[9]  D. Harms,et al.  The Malignant Potential of Teratomas in Infancy and Childhood: The MAKEI Experiences in Non-Testicular Teratoma and Implications for a New Protocol , 2006, Klinische Padiatrie.

[10]  D. Canning Excellent Outcome in Patients With Stage I Germ Cell Tumors of the Testes: A Study of the Children’s Cancer Group/Pediatric Oncology Group , 2005 .

[11]  U. Pichlmeier,et al.  Clinical epidemiology of testicular germ cell tumors , 2004, World Journal of Urology.

[12]  D. Harms,et al.  Epidemiologic analysis of 1,442 children and adolescents registered in the German germ cell tumor protocols , 2004, Pediatric Blood & Cancer.

[13]  J. Mann,et al.  The UK Children's Cancer Study Group: testicular malignant germ cell tumours 1979-1988. , 1990, Journal of pediatric surgery.

[14]  F. Cavalli,et al.  Report on the International Workshop on Staging and Treatment of Testicular Cancer. , 1980, European journal of cancer.

[15]  L. Einhorn,et al.  Chemotherapy of Disseminated Testicular Cancer , 1979 .

[16]  O. Dodge Histological Typing of Testis Tumours (International Histological Classification of Tumours, No. 16) , 1978, British Journal of Cancer.

[17]  P. Exelby,et al.  Malignant scrotal masses in children , 1974, CA: a cancer journal for clinicians.

[18]  W. Whitmore,et al.  Effects of combined drug therapy on metastatic cancer of the testis. , 1960, JAMA.

[19]  D. Canning,et al.  Experience with testis sparing surgery for testicular teratoma. , 2004, The Journal of urology.

[20]  U. Göbel,et al.  [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update]. , 2002, Klinische Padiatrie.

[21]  D. Harms,et al.  Germ-cell tumors in childhood and adolescence. GPOH MAKEI and the MAHO study groups. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  I. Sesterhenn,et al.  Histological Typing of Testis Tumours , 1998, World Health Organization.

[23]  U. Göbel,et al.  Alpha 1-fetoprotein (AFP) reference values in infants up to 2 years of age. , 1998, Pediatric hematology and oncology.

[24]  H. Kienzer,et al.  Risk-adapted treatment choice in stage I nonseminomatous testicular germ cell cancer by regarding vascular invasion in the primary tumor: a prospective trial. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Christian Sommerhoff,et al.  Register und Verbundstudie für Hodentumoren - Bonn, ein multizentrisches Krebsregister: (Planung, Aufbau, EDV-Unterstützung, Ergebnisse) , 1984 .

[26]  D. Harms,et al.  [Pathological anatomy of germ cell tumors (especially testicular tumors) in children]. , 1983, Klinische Padiatrie.